Kong Z and colleagues present evidence suggesting that DAB2IP-deficient prostate cancer cells that have metastasized show greater clonogenic survival when treated with ionizing radiation than control cells expressing normal levels of DAB2IP. This evidence concerns the gene DAB2IP and prostate cancer.